PARP1 and cancer: Mechanistically, mutations in BRCA1/2 inactivate the HR pathway, and in order to survive, BRCA1/2-mutated cancer cells require the activity of PARP1 in BER and/or a-NHEJ, to prevent the formation of DSBs from unrepaired SSBs during DNA replication.